Analysts expect iBio, Inc. to report revenue of 26,270.50 for Q1 27, against a range of 23,684.83 to 28,856.17. The most recent reported quarter, Q4 26, came in at 0.00.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 | Q1 31 | Q2 31 | Q3 31 | Q4 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 200,000.00 | 0.00 | 200,000.00 | 100,000.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||||
| High Estimate | 0.00 | 0.00 | 102,453.83 | 104,269.30 | 33,086.38 | 52,814.64 | 22,079.11 | 0.00 | 28,856.17 | 0.00 | 0.00 | 0.00 | 21,055.07 | 6,651.42 | -13,232.78 | 10,777.68 | ||||||||||||
| Low Estimate | 0.00 | 0.00 | 85,335.17 | 90,713.70 | 30,664.24 | 44,121.86 | 19,291.29 | 0.00 | 23,684.83 | 0.00 | 0.00 | 0.00 | 17,603.27 | 6,034.20 | -14,103.98 | 9,129.88 | ||||||||||||
| Consensus Estimate | 0.00 | 0.00 | 93,894.50 | 97,491.50 | 31,875.31 | 48,468.25 | 20,685.20 | 0.00 | 26,270.50 | 0.00 | 0.00 | 0.00 | 19,329.17 | 6,342.81 | -13,668.38 | 9,953.78 |
Analysts expect iBio, Inc. to report earnings per share of -0.07 for Q1 27, against a range of -0.07 to -0.07. The most recent reported quarter, Q4 26, came in at -0.05, a 28.6% beat against the -0.07 consensus.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 | Q1 31 | Q2 31 | Q3 31 | Q4 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.46 | -0.48 | -0.49 | -0.32 | -0.11 | -0.09 | -0.07 | -0.05 | - | - | - | - | - | - | - | - | ||||||||||||
| High Estimate | -0.47 | -0.42 | -0.31 | -0.33 | -0.19 | -0.13 | -0.05 | -0.07 | -0.07 | -0.07 | -0.08 | -0.09 | -0.11 | -0.14 | -0.16 | -0.13 | ||||||||||||
| Low Estimate | -0.51 | -0.48 | -0.37 | -0.35 | -0.21 | -0.15 | -0.07 | -0.07 | -0.07 | -0.09 | -0.10 | -0.09 | -0.13 | -0.16 | -0.18 | -0.15 | ||||||||||||
| Consensus Estimate | -0.49 | -0.45 | -0.34 | -0.34 | -0.20 | -0.14 | -0.06 | -0.07 | -0.07 | -0.08 | -0.09 | -0.09 | -0.12 | -0.15 | -0.17 | -0.14 |
Pull Wall Street consensus for iBio, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IBIO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IBIO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=IBIO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();